Question
It appears this topic was covered in this forum back in 2012 and the HIDA conference was suggested as a possible resource. I've heard both positive and negative experiences concerning finding medical device distribution partners at HIDA and was hopin...
The story about my financial loss, "We just lost a lot of money, and boy, is my wife upset!" generated more feedback than anything I've shared in my seven years with you. Many wrote me privately about their own flirtations with loss. Others about how...
This is my new stock answer whenever a medical device hopeful needs capital. Fill out this form. If you can't answer the questions on this form, your prospective investors ("smart money," if you will) don't have enough information. Take your pick: as...
When UK-based EnXray, makers of the first low-energy X-ray sterilization tech, needed £400,000 to scale its manufacturing to hit 2018 sales projections, it turned to Crowdcube. "We're 72% to our target raise with 201 investors," states EnXray co-foun...
When UK-based EnXray, makers of the first low-energy X-ray sterilization tech, needed £400,000 to scale its manufacturing to hit 2018 sales projections, it turned to Crowdcube. And fantastic-looking carbon-fiber wheelchair manufacturer Carbon Black i...
25 months ago, we celebrated the two-year delay of the medical device tax. Two weeks ago, we celebrated again with another two-year delay, retroactive to December 31, 2017. +++ Presumably you were preparing for January 29, when the Treasury Departmen...
I can't believe how often I get a message like this one. Below, I'll translate it into my native New York tongue so you hear it the way I heard it. Hey Joe, How's it goin'? Listen, me and the guys are gettin' together and makin' this thing. It's gonn...
Theranos Secures $100 Million in New Funding from Fortress Capital The once-hailed blood-testing startup, led by CEO Elizabeth Holmes, was on the edge of bankruptcy.source: https://www.linkedin.com/groups/78665/78665-6351540835342905346
Medical device founders may clutch tightly to the idea of retaining as much NewCo stock as possible. They viscerally reject the idea of either losing their controlling authority or diluting their equity interest, or both. Early round investors, espec...
Richard A Baron, Dave Sheppard, Teresa Gonzalo, and Enzo Villani led our panel at the 10x Medical Device Conference and you can access the full recording at http://medgroup.biz/funds Among the topics they discussed: What kind of capital should I rais...
